Topical Drug Delivery Market - By Product (Semi-Solid Formulations, Solid Formulations, Liquid Formulations, Transdermal Products), By Route Of Administration (Dermal, Ophthalmic, Nasal, Or Mucosal, Rectal, And Vaginal), By Facility Of Use (Hospital Pharmacies, Homecare Settings, Burn Centres, Other Facilities), And By Region (North America, Asia Pacific, Europe, Middle East & Africa and Latin America) - Industry Analysis, Opportunity and Forecast 2020 To 2027
Published Date: May 2021
No. of Pages: 183
Status: Published
Report Code: ARI100584
Topical drug delivery systems are designed to deliver drugs through topical routes such as the skin, mucosa or cavities in the body. These are applied locally for site specific action or to avoid first pass effect of the drug. Skin is the most readily accessible part of the body with a large surface area and is rich in blood vessels and porous structures, enhancing the absorption of the drugs. The topical drug delivery system has witnessed technological advancements over a period of time and is attracting many researchers to develop novel products in this area. Common skin diseases that are treated preferably by topical drug delivery system include bacterial infections, fungal infections, inflammations and pruritic manifestations, acne, psoriasis, hair and skin problems, and others. Nasal mucosa is highly perfused with blood vessels and has been proven as a site for faster absorption of drugs. Hence, there is increasing research toward the development of targeted drug delivery systems for nasal route. Topical is a highly preferred route of drug administration for the treatment of ocular disorders owing to its site-specific action, reduced first pass metabolism, and faster action.
The growing incidence and prevalence rate of tropical diseases is boosting the growth of the topical drug delivery systems market. According to the American Academy of Dermatology, in the U.S., about 50 million people are affected by acne each year. The global topical drug delivery systems market is expected to expand at a fast growth rate during the forecast period owing to factors such as increasing number of patients with skin diseases, preference for novel transdermal delivery systems, growing patient preference towards topical drugs over oral drugs owing to avoidance of bitter taste of the drugs taken orally, and desired site-specific actions to treat many disorders. However, high development cost, different solubility profiles of drugs making product formulation challenging, stringent regulatory requirements, and difficult testing procedure of final products are some of the factors restraining the growth of the global market.
Prominent players in the topical drug delivery market are Johnson & Johnson (US), Nestle SA (Switzerland), Novartis AG (Switzerland), GlaxoSmithKline (UK), Bausch Health Companies (Canada), Merck & Co (US), Bayer AG (Germany), Hisamitsu Pharmaceutical (Japan), Glenmark Pharmaceuticals (India), Cipla Ltd (India), Crescita Therapeutics Inc. (Canada), and Mylan (US).
Janssen Global Services is a subsidiary of Johnson & Johnson. Janssen provides medicines for a wide array of health concerns in several therapeutic areas, including ADHD, general medicine, mental health, neurology, pain management, and women’s health. The company sells its products through a network of distributors across the US. It operates through three business segments, namely, Pharmaceutical, Consumer, and Medical Devices. It offers topical products through its pharmaceutical and consumer segments.
Analyst Commentary
The high prevalence of skin & eye diseases, high incidence of burn injuries, and the growing prevalence of diabetes driving the demand for topical drug delivery. However, technical barriers related to skin irritation and permeability and drug failures and product recalls are the challenges associated with this market.
On the basis of product, the semi-solid formulations segment is expected to account the largest market share of the market in 2020. The advantages of semi-solid formulations such as faster drug release and greater patient acceptability topical gels, wide applications of topical pastes for the treatment and prevention of skin irritation, high spread ability and washability of creams for the treatment of various skin types are the factors driving the growth of this market.
On the basis of route of administration, the dermal drug delivery segment accounted for the largest share of the market in 2018. This is mainly due to the high prevalence of skin diseases across the globe. For instance, the prevalence of psoriasis worldwide ranges between 0.09% and 11.43%, making it a serious global problem with at least 100 million individuals affected worldwide. (Source: WHO 2016).
On the basis of facility of use, Homecare settings accounted for the largest share of the market in 2018. Home care settings eliminate the need for patients to travel to healthcare facilities, thus saving time and money. Owing to this convenience and better affordability, an increasing number of patients are opting for home-based treatments, and these are some of the key factors driving the growth of this facility of use segment.
Segmentation
The global topical drug delivery systems market is segmented based on product, route of administration, Facility of use, and region. By product, the market is segmented into semi-solid formulations (creams, gels, ointments, pastes, and lotions), solid formulations (suppositories and powders), liquid formulations (solutions and suspensions), and transdermal products (transdermal patches and transdermal semi-solids). Based on route of administration, the global market is segmented into dermal, ophthalmic, nasal, or mucosal, rectal, and vaginal. In terms of Facility of use, the market is categorized into hospital pharmacies, Homecare Settings, Burn Centres, Other Facilities (academic & research institutes and diagnostic centres).
Regional Analysis
Geographically, the global topical drug delivery systems market is distributed over North America, Europe, Asia Pacific, Latin America, and Middle East & Africa North America dominated the market in 2018. Though, the North America region is expected to witness the highest CAGR during the forecast period. The rising prevalence of skin diseases, approvals, and launches of innovative topical formulations in the region, and funding for the development of topical drugs are some of the key factors driving the growth of this regional segment. For instance, in December 2018, Cipher Pharmaceuticals Inc. (Canada) received acceptance for its “A-101 40% topical solution” for review by Health Canada. This product is indicated for the treatment of raised seborrheic keratosis, which is a commonly occurring non-cancerous skin growth that affects more than 9 million Canadian adults. Similarly, in December 2018, GlaxoSmithKline (UK) invested USD 36.0 million in manufacturing sites in Canada to boost the production and support delivery of its leading topical pain reliever—VOLTAREN.
Europe is the second largest market due to growing geriatric population, increasing R&D investments, and rising adoption of novel drug delivery systems to treat chronic dermatological conditions. Asia Pacific is considered as an emerging market owing to higher prevalence of skin diseases due to unhealthy lifestyle among general population, and lack of hygiene, along with increasing awareness and accessibility for topical drugs for treatment of various diseases.
TABLE OF CONTENTS
Chapter 1. Executive Summary
Chapter 2. Research Methodology
2.1. Research approach
2.2. Scope, definition, and assumptions
2.3. Data Component
2.3.1. Secondary Component
2.3.1.1. Preliminary data mining
2.3.2. Primary Component
2.3.2.1. Statistical Model
2.3.2.2. Data Triangulation
2.3.2.3. Research Objective
Chapter 3. Market Outlook
3.1. Introduction
3.2. Key trends
3.2.1. xx
3.3. Market drivers
3.3.1. Impact analysis of Market Drivers
3.4. Market restraints
3.4.1. Impact analysis of Market Restraints
3.5. Market opportunities
3.5.1. Impact analysis of Market Opportunities
3.6. Market Challenges
3.6.1. Impact analysis of Market Trends
3.7. Porter’s Five Forces’ analysis
3.7.1. Bargaining Power of Suppliers
3.7.2. Bargaining Power of Buyers
3.7.3. Threat of New Entrant
3.7.4. Threat of Substitutes
3.7.5. High Competitive Rivalry
3.8. Value chain analysis
Chapter 4. COVID-19 Impact On Tropical Drug Delivery Market
Chapter 5. Global Tropical Drug Delivery Market Overview, By Product, 2015 - 2027(USD Billion)
5.1. Global Tropical Drug Delivery Market Share, By Product, 2015 - 2027 (USD Billion)
5.1.1. Creams
5.1.1.1. Market Type and Projections,2015 - 2027 (USD Billion)
5.1.1.2. Market Type and Projections, by Region, 2015 - 2027 (USD Billion)
5.1.2. Gels
5.1.2.1. Market Type and Projections,2015 - 2027 (USD Billion)
5.1.2.2. Market Type and Projections, by Region, 2015 - 2027 (USD Billion)
5.1.3. Ointments
5.1.3.1. Market Type and Projections,2015 - 2027 (USD Billion)
5.1.3.2. Market Type and Projections, by Region, 2015 - 2027 (USD Billion)
5.1.4. Pastes
5.1.4.1. Market Type and Projections,2015 - 2027 (USD Billion)
5.1.4.2. Market Type and Projections, by Region, 2015 - 2027 (USD Billion)
5.1.5. Lotions
5.1.5.1. Market Type and Projections,2015 - 2027 (USD Billion)
5.1.5.2. Market Type and Projections, by Region, 2015 - 2027 (USD Billion)
5.1.6. Suppositories
5.1.6.1. Market Type and Projections,2015 - 2027 (USD Billion)
5.1.6.2. Market Type and Projections, by Region, 2015 - 2027 (USD Billion)
5.1.7. Powders
5.1.7.1. Market Type and Projections,2015 - 2027 (USD Billion)
5.1.7.2. Market Type and Projections, by Region, 2015 - 2027 (USD Billion)
5.1.8. Hospital Pharmacies
5.1.8.1. Market Type and Projections,2015 - 2027 (USD Billion)
5.1.8.2. Market Type and Projections, by Region, 2015 - 2027 (USD Billion)
5.1.9. Suspensions
5.1.9.1. Market Type and Projections,2015 - 2027 (USD Billion)
5.1.9.2. Market Type and Projections, by Region, 2015 - 2027 (USD Billion)
5.1.10. Transdermal patches
5.1.10.1. Market Type and Projections,2015 - 2027 (USD Billion)
5.1.10.2. Market Type and Projections, by Region, 2015 - 2027 (USD Billion)
5.1.11. Transdermal semi-solids
5.1.11.1. Market Type and Projections,2015 - 2027 (USD Billion)
5.1.11.2. Market Type and Projections, by Region, 2015 - 2027 (USD Billion)
Chapter 6. Global Tropical Drug Delivery Market Overview, By Route of Administration, 2015 - 2027(USD Billion)
6.1. Global Tropical Drug Delivery Market Share, By Route of Administration, 2015 - 2027 (USD Billion)
6.1.1. Dermal
6.1.1.1. Market Type and Projections,2015 - 2027 (USD Billion)
6.1.1.2. Market Type and Projections, by Region, 2015 - 2027 (USD Billion)
6.1.2. Ophthalmic
6.1.2.1. Market Type and Projections, 2015 - 2027 (USD Billion)
6.1.2.2. Market Type and Projections, by Region, 2015 - 2027 (USD Billion)
6.1.3. Nasal
6.1.3.1. Market Type and Projections, 2015 - 2027 (USD Billion)
6.1.3.2. Market Type and Projections, by Region, 2015 - 2027 (USD Billion)
6.1.4. Oromucosal
6.1.4.1. Market Type and Projections, 2015 - 2027 (USD Billion)
6.1.4.2. Market Type and Projections, by Region, 2015 - 2027 (USD Billion)
6.1.5. Rectal
6.1.5.1. Market Type and Projections, 2015 - 2027 (USD Billion)
6.1.5.2. Market Type and Projections, by Region, 2015 - 2027 (USD Billion)
6.1.6. Vaginal
6.1.6.1. Market Type and Projections, 2015 - 2027 (USD Billion)
6.1.6.2. Market Type and Projections, by Region, 2015 - 2027 (USD Billion)
Chapter 7. Global Tropical Drug Delivery Market Overview, By Facility of Use, 2015 - 2027(USD Billion)
7.1. Global Tropical Drug Delivery Market Share, By Facility of Use, 2015 - 2027 (USD Billion)
7.1.1. Hospital Pharmacies
7.1.1.1. Market Type and Projections,2015 - 2027 (USD Billion)
7.1.1.2. Market Type and Projections, by Region, 2015 - 2027 (USD Billion)
7.1.2. Homecare Settings
7.1.2.1. Market Type and Projections, 2015 - 2027 (USD Billion)
7.1.2.2. Market Type and Projections, by Region, 2015 - 2027 (USD Billion)
7.1.3. Burn Centres
7.1.3.1. Market Type and Projections, 2015 - 2027 (USD Billion)
7.1.3.2. Market Type and Projections, by Region, 2015 - 2027 (USD Billion)
7.1.4. Others
7.1.4.1. Market Type and Projections, 2015 - 2027 (USD Billion)
7.1.4.2. Market Type and Projections, by Region, 2015 - 2027 (USD Billion)
Chapter 8. Global Tropical Drug Delivery Market Overview, By Geography, 2015 - 2027(USD Billion)
8.1. Global Tropical Drug Delivery Market Share, By Geography, 2015 - 2027(USD Billion)
8.1.1. Market Type and projections, by Countries, 2015 - 2027 (USD Billion)
8.1.2. Market Share and CAGR Comparison, by Countries, 2020 - 2027 (%)
Chapter 9. North America Tropical Drug Delivery Market Overview, By Countries, 2015 - 2027(USD Billion)
9.1. North America Tropical Drug Delivery Market Overview, 2015 - 2027 (USD Billion)
9.1.1. Market Type and projections, 2015 - 2027 (USD Billion)
9.1.2. North America Tropical Drug Delivery Market Overview, By Product, 2015 - 2027 (USD Billion)
9.1.3. North America Tropical Drug Delivery Market Overview, By Route of Administration, 2015 - 2027 (USD Billion)
9.1.4. North America Tropical Drug Delivery Market Overview, By Facility of Use, 2015 - 2027 (USD Billion)
9.1.5. North America Tropical Drug Delivery Market Overview, By Countries, 2015 - 2027 (USD Billion)
9.1.5.1. U.S. Tropical Drug Delivery Market Overview, 2015 - 2027 (USD Billion)
9.1.5.1.1. Market Type and projections, 2015 - 2027 (USD Billion)
9.1.5.1.2. U.S. Tropical Drug Delivery Market Overview, By Product, 2015 - 2027 (USD Billion)
9.1.5.1.3. U.S. Tropical Drug Delivery Market Overview, By Route of Administration, 2015 - 2027 (USD Billion)
9.1.5.1.4. Other Segment
9.1.5.2. Canada Tropical Drug Delivery Market Overview, 2015 - 2027 (USD Billion)
9.1.5.2.1. Market Type and projections, 2015 - 2027 (USD Billion)
9.1.5.2.2. Canada Tropical Drug Delivery Market Overview, By Product, 2015 - 2027 (USD Billion)
9.1.5.2.3. Canada Tropical Drug Delivery Market Overview, By Route of Administration, 2015 - 2027 (USD Billion)
9.1.5.2.4. Other Segment
9.1.5.3. Mexico Tropical Drug Delivery Market Overview, 2015 - 2027 (USD Billion)
9.1.5.3.1. Market Type and projections, 2015 - 2027 (USD Billion)
9.1.5.3.2. Mexico Tropical Drug Delivery Market Overview, By Product, 2015 - 2027 (USD Billion)
9.1.5.3.3. Mexico Tropical Drug Delivery Market Overview, By Route of Administration, 2015 - 2027 (USD Billion)
9.1.5.3.4. Other Segment
Chapter 10. Europe Tropical Drug Delivery Market Overview, By Countries, 2015 - 2027(USD Billion)
10.1. Europe Tropical Drug Delivery Market Overview, 2015 - 2027 (USD Billion)
10.1.1. Market Type and projections, 2015 - 2027 (USD Billion)
10.1.2. Europe Tropical Drug Delivery Market Overview, By Product, 2015 - 2027 (USD Billion)
10.1.3. Europe Tropical Drug Delivery Market Overview, By Route of Administration, 2015 - 2027 (USD Billion)
10.1.4. Europe Tropical Drug Delivery Market Overview, By Facility of Use,2015 - 2027 (USD Billion)
10.1.5. Europe Skin Care Types Market Overview, By Countries, 2015 - 2027 (USD Billion)
10.1.5.1. Germany
10.1.5.1.1. Market Type and projections, 2015 - 2027 (USD Billion)
10.1.5.1.2. Germany Tropical Drug Delivery Market Overview, By Product, 2015 - 2027(USD Billion)
10.1.5.1.3. Germany Tropical Drug Delivery Market Overview, By Route of Administration, 2015 - 2027(USD Billion)
10.1.5.1.4. Other Segments
10.1.5.2. France
10.1.5.2.1. Market Type and projections, 2015 - 2027 (USD Billion)
10.1.5.2.2. France Tropical Drug Delivery Market Overview, By Product, 2015 - 2027(USD Billion)
10.1.5.2.3. France Tropical Drug Delivery Market Overview, By Route of Administration, 2015 - 2027(USD Billion)
10.1.5.2.4. Other Segments
10.1.5.3. UK
10.1.5.3.1. Market Type and projections, 2015 - 2027 (USD Billion)
10.1.5.3.2. UK Tropical Drug Delivery Market Overview, By Product, 2015 - 2027(USD Billion)
10.1.5.3.3. UK Tropical Drug Delivery Market Overview, By Route of Administration, 2015 - 2027(USD Billion)
10.1.5.3.4. Other Segments
10.1.5.4. Italy
10.1.5.4.1. Market Type and projections, 2015 - 2027 (USD Billion)
10.1.5.4.2. Italy Tropical Drug Delivery Market Overview, By Product, 2015 - 2027(USD Billion)
10.1.5.4.3. Italy Tropical Drug Delivery Market Overview, By Route of Administration 2015 - 2027(USD Billion)
10.1.5.4.4. Other Segments
10.1.5.5. Spain
10.1.5.5.1. Market Type and projections, 2015 - 2027 (USD Billion)
10.1.5.5.2. Spain Tropical Drug Delivery Market Overview, By Product, 2015 - 2027(USD Billion)
10.1.5.5.3. Spain Tropical Drug Delivery Market Overview, By Route of Administration, 2015 - 2027(USD Billion)
10.1.5.5.4. Other Segments
10.1.5.6. Rest of Europe
10.1.5.6.1. Market Type and projections, 2015 – 2027
10.1.5.6.2. Rest of Europe Tropical Drug Delivery Market Overview, By Product, 2015 - 2027(USD Billion)
10.1.5.6.3. Rest of Europe Tropical Drug Delivery Market Overview, By Route of Administration, 2015 - 2027(USD Billion)
10.1.5.6.4. Other Segments
Chapter 11. Asia Pacific Tropical Drug Delivery Market Overview, By Countries, 2015 - 2027 (USD Billion)
11.1. Asia Pacific Tropical Drug Delivery Market Overview, 2015 - 2027 (USD Billion)
11.1.1. Market Type and projections, 2015 - 2027 (USD Billion)
11.1.2. Asia Pacific Tropical Drug Delivery Market Overview, By Product, 2015 - 2027 (USD Billion)
11.1.3. Asia Pacific Tropical Drug Delivery Market Overview, By Route of Administration, 2015 - 2027 (USD Billion)
11.1.4. Asia Pacific Tropical Drug Delivery Market Overview, By Facility of Use,2015 - 2027 (USD Billion)
11.1.5. Asia Pacific Tropical Drug Delivery Market Overview, By Countries, 2015 - 2027 (USD Billion)
11.1.5.1. India
11.1.5.1.1. Market Type and projections, 2015 - 2027 (USD Billion)
11.1.5.1.2. India Tropical Drug Delivery Market Overview, By Product, 2015 - 2027(USD Billion)
11.1.5.1.3. India Tropical Drug Delivery Market Overview, By Route of Administration, 2015 - 2027 (USD Billion)
11.1.5.1.4. Other Segments
11.1.5.2. China
11.1.5.2.1. Market Type and projections, 2015 - 2027(USD Billion)
11.1.5.2.2. China Tropical Drug Delivery Market Overview, By Product, 2015 - 2027(USD Billion)
11.1.5.2.3. China Tropical Drug Delivery Market Overview, By Route of Administration, 2015 - 2027 (USD Billion)
11.1.5.2.4. Other Segments
11.1.5.3. Japan
11.1.5.3.1. Market Type and projections, 2015 - 2027 (USD Billion)
11.1.5.3.2. Japan Tropical Drug Delivery Market Overview, By Product, 2015 - 2027(USD Billion)
11.1.5.3.3. Japan Tropical Drug Delivery Market Overview, By Route of Administration, 2015 - 2027(USD Billion)
11.1.5.3.4. Other Segments
11.1.5.4. South Korea
11.1.5.4.1. Market Type and projections, 2015 - 2027(USD Billion)
11.1.5.4.2. South Korea Tropical Drug Delivery Market Overview, By Product, 2015 - 2027(USD Billion)
11.1.5.4.3. South Korea Tropical Drug Delivery Market Overview, By Route of Administration, 2015 - 2027 (USD Billion)
11.1.5.4.4. Other Segments
11.1.5.5. Rest of Asia Pacific
11.1.5.5.1. Market Type and projections, 2015 - 2027 (USD Billion)
11.1.5.5.2. Rest of Asia Pacific Tropical Drug Delivery Market Overview, By Product, 2015 - 2027(USD Billion)
11.1.5.5.3. Rest of Asia Pacific Tropical Drug Delivery Market Overview, By Route of Administration, 2015 - 2027 (USD Billion)
11.1.5.5.4. Other Segments
Chapter 12. Middle East & Africa Tropical Drug Delivery Market Overview, By Countries, 2015 - 2027 (USD Billion)
12.1. Middle East & Africa Tropical Drug Delivery Market Overview, 2015 - 2027 (USD Billion)
12.1.1. Market Type and projections, 2015 - 2027 (USD Billion)
12.1.2. Middle East & Africa Tropical Drug Delivery Market Overview, By Product, 2015 - 2027 (USD Billion)
12.1.3. Middle East & Africa Tropical Drug Delivery Market Overview, By Route of Administration, 2015 - 2027 (USD Billion)
12.1.4. Middle East & Africa Tropical Drug Delivery Market Overview, By Facility of Use,2015 - 2027 (USD Billion)
12.1.5. Middle East & Africa Tropical Drug Delivery Market Overview, By Countries, 2015 - 2027 (USD Billion)
12.1.5.1. GCC
12.1.5.1.1. Market Type and projections, 2015 - 2027 (USD Billion)
12.1.5.1.2. GCC Tropical Drug Delivery Market Overview, By Product, 2015 - 2027 (USD Billion)
12.1.5.1.3. GCC Tropical Drug Delivery Market Overview, By Route of Administration, 2015 - 2027 (USD Billion)
12.1.5.1.4. Other Segments
12.1.5.2. South Africa
12.1.5.2.1. Market Type and projections, 2015 - 2027 (USD Billion)
12.1.5.2.2. South Africa Tropical Drug Delivery Market Overview, By Product, 2015 - 2027 (USD Billion)
12.1.5.2.3. South Africa Tropical Drug Delivery Market Overview, By Route of Administration, 2015 - 2027 (USD Billion)
12.1.5.2.4. Other Segments
12.1.5.3. Rest of Middle East & Africa
12.1.5.3.1. Market Type and projections, 2015 - 2027 (USD Billion)
12.1.5.3.2. Rest of Middle East & Africa Tropical Drug Delivery Market Overview, By Product, 2015 - 2027 (USD Billion)
12.1.5.3.3. Rest of Middle East & Africa Tropical Drug Delivery Market Overview, By Route of Administration, 2015 - 2027 (USD Billion)
12.1.5.3.4. Other Segments
Chapter 13. South America Tropical Drug Delivery Market Overview, By Countries, 2015 - 2027 (USD Billion)
13.1. South America Tropical Drug Delivery Market Overview, 2015 - 2027 (USD Billion)
13.1.1. Market Type and projections, 2015 - 2027 (USD Billion)
13.1.2. South America Tropical Drug Delivery Market Overview, By Product, 2015 - 2027 (USD Billion)
13.1.3. South America Tropical Drug Delivery Market Overview, By Route of Administration, 2015 - 2027 (USD Billion)
13.1.4. South America Tropical Drug Delivery Market Overview, By Facility of Use,2015 - 2027 (USD Billion)
13.1.5. South America Tropical Drug Delivery Market Overview, By Countries, 2015- 2026 (USD Billion)
13.1.6. Brazil
13.1.6.1. Market Type and projections, 2015 - 2027 (USD Billion)
13.1.6.2. Brazil Tropical Drug Delivery Market Overview, By Product, 2015 - 2027 (USD Billion)
13.1.6.3. Brazil Tropical Drug Delivery Market Overview, By Route of Administration, 2015 - 2027 (USD Billion)
13.1.6.4. Other Segments
13.1.7. Argentina
13.1.7.1. Market Type and projections, 2015 - 2027 (USD Billion)
13.1.7.2. Argentina Tropical Drug Delivery Market Overview, By Product, 2015 - 2027 (USD Billion)
13.1.7.3. Argentina Tropical Drug Delivery Market Overview, By Route of Administration, 2015 - 2027 (USD Billion)
13.1.7.4. Other Segments
13.1.8. Rest of South America
13.1.8.1. Market Type and projections, 2015 – 2027
13.1.8.2. Rest of South America Tropical Drug Delivery Market Overview, By Product, 2015 - 2027 (USD Billion)
13.1.8.3. Rest of South America Tropical Drug Delivery Market Overview, By Route of Administration, 2015 - 2027 (USD Billion)
13.1.8.4. Other Segments
Chapter 14. Competitive Landscape
14.1. Competitive environment, 2020
14.2. Strategic framework
14.2.1. Partnership/agreement
14.2.2. Expansion
14.2.3. Mergers & Acquisitions
14.2.4. New Type development
Chapter 15. Key Vendor Analysis
15.1. Johnson & Johnson
15.1.1. Company overview
15.1.2. Financial performance
15.1.3. Product Benchmarking
15.1.4. Recent initiatives
15.1.5. SWOT analysis
15.2. Nestle SA
15.2.1. Company overview
15.2.2. Financial performance
15.2.3. Product Benchmarking
15.2.4. Recent initiatives
15.2.5. SWOT analysis
15.3. Novartis AG
15.3.1. Company overview
15.3.2. Financial performance
15.3.3. Product Benchmarking
15.3.4. Recent initiatives
15.4. GlaxoSmithKline
15.5. Bausch Health Companies
15.6. Merck & Co.
15.7. Bayer AG
15.8. Hisamitsu Pharmaceuticals
15.9. Glenmark Pharmaceuticals
15.10. Cipla Ltd.
15.11. Crescita Therapeutics Inc.
15.12. Mylan
Chapter 16. Tropical Drug Delivery Market Cost Analysis
16.1. Tropical Drug Delivery Market Key Type Analysis
16.1.1. Key Type
16.1.2. Price Trend of Key Type
16.1.3. Key Suppliers of Type
16.1.4. Market Concentration Rate of Type
16.1.5. Labor Cost
Chapter 17. Sourcing Strategy and Downstream Buyers
17.1. Tropical Drug Delivery Market Chain Analysis
17.2. Upstream Type Sourcing
17.3. Tropical Drug Delivery Market Major Manufacturers in 2021
17.4. Downstream Buyers
Chapter 18. Marketing Strategy Analysis, Distributors/Traders
18.1. Marketing Channel
18.1.1. Direct Marketing
18.1.2. Indirect Marketing
18.1.3. Marketing Channel Development Trend
18.2. Market Positioning
18.2.1. Pricing Strategy
18.2.2. Brand Strategy
18.2.3. Target Client
18.3. Distributors/Traders List
Chapter 19. Market Effect Factors Analysis
19.1. Technology Progress/Risk
19.1.1. Substitutes Threat
19.1.2. Technology Progress in Related Type
19.2. Consumer Needs/Customer Preference Change
19.3. Economic/Political Environmental Change
Chapter 20. Future Outlook of the Market
Disclaimer
List of Figures
1. Market segmentation
2. Value chain analysis
3. Porter’s Five Forces’ analysis
4. Power of Suppliers
5. Power of Buyers
6. Threat of New Entrants
7. Threat of Substitute
8. Competitive Rivalry
9. Global Tropical Drug Delivery Market share, By Product, 2020 & 2027 (%)
10. Global Tropical Drug Delivery Market share, by Creams, By Product, 2015 - 2027 (USD Billion)
11. Global Tropical Drug Delivery Market share, by Gels, By Product, 2015 - 2027 (USD Billion)
12. Global Tropical Drug Delivery Market share, by Creams, By Product, 2015 - 2027 (USD Billion)
13. Global Tropical Drug Delivery Market share, by Ointments, By Product, 2015 - 2027 (USD Billion)
14. Global Tropical Drug Delivery Market share, by Pastes, By Product, 2015 - 2027 (USD Billion)
15. Global Tropical Drug Delivery Market share, by Lotions, By Product, 2015 - 2027 (USD Billion)
16. Global Tropical Drug Delivery Market share, by Suppositories, By Product, 2015 - 2027 (USD Billion)
17. Global Tropical Drug Delivery Market share, by Powders, By Product, 2015 - 2027 (USD Billion)
18. Global Tropical Drug Delivery Market share, by Solutions, By Product, 2015 - 2027 (USD Billion)
19. Global Tropical Drug Delivery Market share, by Suspensions, By Product, 2015 - 2027 (USD Billion)
20. Global Tropical Drug Delivery Market share, by Transdermal patches, By Product, 2015 - 2027 (USD Billion)
21. Global Tropical Drug Delivery Market share, by Transdermal semi-solids, By Product, 2015 - 2027 (USD Billion)
22. Global Tropical Drug Delivery Market share, By Route of Administration, 2020 & 2027 (%)
23. Global Tropical Drug Delivery Market share, by Dermal, By Route of Administration, 2015 - 2027 (USD Billion)
24. Global Tropical Drug Delivery Market share, by Ophthalmic, By Route of Administration 2015 - 2027 (USD Billion)
25. Global Tropical Drug Delivery Market share, by Nasal, By Route of Administration 2015 - 2027 (USD Billion)
26. Global Tropical Drug Delivery Market share, by Oromucosal, By Route of Administration 2015 - 2027 (USD Billion)
27. Global Tropical Drug Delivery Market share, by Rectal, By Route of Administration 2015 - 2027 (USD Billion)
28. Global Tropical Drug Delivery Market share, by Vaginal, By Route of Administration 2015 - 2027 (USD Billion)
29. Global Tropical Drug Delivery Market share, By Facility of Use, 2020 & 2027 (%)
30. Global Tropical Drug Delivery Market share, by Hospital Pharmacies, By Facility of Use, 2015 - 2027 (USD Billion)
31. Global Tropical Drug Delivery Market share, by Homecare Settings, By Facility of Use 2015 - 2027 (USD Billion)
32. Global Tropical Drug Delivery Market share, by Burn Centres, By Facility of Use 2015 - 2027 (USD Billion)
33. Global Tropical Drug Delivery Market share, by Others, By Facility of Use 2015 - 2027 (USD Billion)
34. Global Tropical Drug Delivery Market share, by region, 2020 & 2027 (%)
35. Global Tropical Drug Delivery Market share, by region, 2015 - 2027(USD Billion)
36. North America Tropical Drug Delivery Market, 2015 - 2027(USD Billion)
37. North America Tropical Drug Delivery Market share, by Countries, 2020 & 2027 (%)
38. U.S. Tropical Drug Delivery Market, 2015 - 2027(USD Billion)
39. Canada Tropical Drug Delivery Market, 2015 - 2027(USD Billion)
40. Europe Tropical Drug Delivery Market, 2015 - 2027(USD Billion)
41. Europe Tropical Drug Delivery Market share, by Countries, 2020 & 2027 (%)
42. Spain Tropical Drug Delivery Market, 2015 - 2027(USD Billion)
43. UK Tropical Drug Delivery Market, 2015 - 2027(USD Billion)
44. Italy Tropical Drug Delivery Market, 2015 - 2027(USD Billion)
45. Germany Tropical Drug Delivery Market, 2015 - 2027(USD Billion)
46. France Tropical Drug Delivery Market, 2015 - 2027(USD Billion)
47. Rest of Europe Tropical Drug Delivery Market, 2015 - 2027(USD Billion)
48. Asia-Pacific Tropical Drug Delivery Market, 2015 - 2027(USD Billion)
49. Asia-Pacific Tropical Drug Delivery Market share, by Countries, 2020 & 2027 (%)
50. China Tropical Drug Delivery Market, 2015 - 2027(USD Billion)
51. India Tropical Drug Delivery Market, 2015 - 2027(USD Billion)
52. Australia Tropical Drug Delivery Market, 2015 - 2027(USD Billion)
53. Japan Tropical Drug Delivery Market, 2015 - 2027(USD Billion)
54. Rest of Asia-Pacific Tropical Drug Delivery Market, 2015 - 2027(USD Billion)
55. Middle East & Africa Tropical Drug Delivery Market, 2015 - 2027(USD Billion)
56. Middle East & Africa Tropical Drug Delivery Market share, by Countries, 2020 & 2027 (%)
57. GCC Tropical Drug Delivery Market, 2015 - 2027(USD Billion)
58. South Africa Tropical Drug Delivery Market, 2015 - 2027(USD Billion)
59. Rest Of Middle East & Africa Tropical Drug Delivery Market, 2015 - 2027(USD Billion)
60. South America Tropical Drug Delivery Market, 2015 - 2027(USD Billion)
61. Brazil Tropical Drug Delivery Market, 2015 - 2027(USD Billion)
62. Mexico Tropical Drug Delivery Market, 2015 - 2027(USD Billion)
63. Argentina Tropical Drug Delivery Market, 2015 - 2027(USD Billion)
64. Rest Of South America Tropical Drug Delivery Market, 2015 - 2027(USD Billion)
List of Tables
1. Impact of Market drivers
2. Impact of Market restraints
3. Global Tropical Drug Delivery Market, 2015-2027 (USD Billion)
4. Tropical Drug Delivery requirement, by country, 2015-2027, (USD Billion)
5. North America Tropical Drug Delivery Market, By Product, 2015-2027 (USD Billion)
6. North America Tropical Drug Delivery Market, By Route of Administration, 2015-2027 (USD Billion)
7. North America Tropical Drug Delivery Market, By Facility of Use, 2015-2027 (USD Billion)
8. Europe Tropical Drug Delivery Market, By Product, 2015-2027 (USD Billion)
9. Europe Tropical Drug Delivery Market, By Route of Administration, 2015-2027 (USD Billion)
10. Europe Tropical Drug Delivery Market, By Facility of Use, 2015-2027 (USD Billion)
11. Asia Pacific Tropical Drug Delivery Market, By Product, 2015-2027 (USD Billion)
12. Asia Pacific Tropical Drug Delivery Market, By Route of Administration, 2015-2027 (Revenue, USD Billion)
13. Asia Pacific Tropical Drug Delivery Market, By Facility of Use, 2015-2027 (Revenue, USD Billion)
14. Middle East & Africa Tropical Drug Delivery Market, By Product, 2015-2027 (USD Billion)
15. Middle East & Africa Tropical Drug Delivery Market, By Route of Administration, 2015-2027 (USD Billion)
16. Middle East & Africa Tropical Drug Delivery Market, By Facility of Use, 2015-2027 (USD Billion)
17. South America Tropical Drug Delivery Market, By Product, 2015-2027 (USD Billion)
18. South America Tropical Drug Delivery Market, By Route of Administration, 2015-2027 (USD Billion)
19. South America Tropical Drug Delivery Market, By Facility of Use, 2015-2027 (USD Billion)
20. Global Tropical Drug Delivery Market, Company Market Share, 2020 - 2027 (%)
21. Johnson & Johnson : Deployment model Benchmarking
22. Johnson & Johnson : Financial Performance
23. Nestle SA : Deployment model Benchmarking
24. Nestle SA : Financial Performance
25. Novartis AG, GlaxoSmithKline: Deployment model Benchmarking
26. Novartis AG, GlaxoSmithKline: Financial Performance
27. Bausch Health Companies :Deployment model Benchmarking
28. Bausch Health Companies : Financial Performance
29. Merck & Co. : Deployment model Benchmarking
30. Merck & Co. : Financial Performance
31. Bayer AG : Product Benchmarking
32. 34. Bayer AG : Financial Performance
33. Hisamitsu Pharmaceutical : Product Benchmarking
34. Hisamitsu Pharmaceutical : Financial Performance
35. Glenmark Pharmaceuticals : Product Benchmarking
36. Glenmark Pharmaceuticals : Financial Performance
37. Cipla Ltd. : Product Benchmarking
38. Cipla Ltd. : Financial Performance
39. Crescita Therapeutics Inc : Product Benchmarking
40. Crescita Therapeutics Inc : Financial Performance
41. Mylan : Product Benchmarking
42. Mylan : Financial Performance
The Leading Key Players in Topical Drug Delivery Market
Johnson & Johnson (US)
Nestle SA (Switzerland)
Novartis AG (Switzerland)
GlaxoSmithKline (UK)
Bausch Health Companies (Canada)
Merck & Co (US)
Bayer AG (Germany)
Hisamitsu Pharmaceutical (Japan)
Glenmark Pharmaceuticals (India)
Cipla Ltd (India)
Crescita Therapeutics Inc. (Canada)
Mylan (US).
